Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer

Sarah Hamdy Ahmed(Cairo University), Sherif Ibrahim(Cairo University)

PLoS ONE

April 26, 2021

10.1371/journal.pone.0250642

Cited by 42

Related Papers

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

|Molecular Cancer|2017|276

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling

|PLoS ONE|2013|117